Theresa Matkovits
2019
In 2019, Theresa Matkovits earned a total compensation of $698.1K as Chief Development Officer at Matinas BioPharma Holdings, a 128% increase compared to previous year.
Compensation breakdown
| Bonus | $30,625 |
|---|---|
| Option Awards | $317,513 |
| Salary | $350,000 |
| Total | $698,138 |
Matkovits received $350K in salary, accounting for 50% of the total pay in 2019.
Matkovits also received $30.6K in bonus and $317.5K in option awards.
Rankings
In 2019, Theresa Matkovits' compensation ranked 10,696th out of 13,971 executives tracked by ExecPay. In other words, Matkovits earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,696 out of 13,971 | 23rd |
Division Manufacturing | 4,325 out of 5,695 | 24th |
Major group Chemicals And Allied Products | 1,678 out of 2,194 | 24th |
Industry group Drugs | 1,435 out of 1,880 | 24th |
Industry Pharmaceutical Preparations | 1,062 out of 1,392 | 24th |
Source: SEC filing on October 1, 2020.
Matkovits' colleagues
We found four more compensation records of executives who worked with Theresa Matkovits at Matinas BioPharma Holdings in 2019.
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019